manidipine has been researched along with Hypertension, Malignant in 2 studies
Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ohta, Y | 1 |
Chikugo, T | 1 |
Suzuki, T | 1 |
Chichibu, S | 1 |
Okamura, M | 1 |
Konishi, Y | 1 |
Nishimura, M | 1 |
Negoro, N | 1 |
Umetani, N | 1 |
Inoue, T | 1 |
Kanayama, Y | 1 |
Takeda, T | 1 |
2 other studies available for manidipine and Hypertension, Malignant
Article | Year |
---|---|
Electroencephalographic evaluation of the therapeutic efficiency of antihypertensive agents on M-SHRSP.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Wei | 1995 |
Platelet-derived growth factor gene expression in the kidney of malignant hypertension.
Topics: Animals; Base Sequence; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models, | 1992 |